Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Joshua Barnett & Sofia Pappa. (2023) Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety. Patient Preference and Adherence 17, pages 1603-1610.
Read now
Read now
Jason Shafrin, Katalin Bognar, Katie Everson, Michelle Brauer, Darius N Lakdawalla & Felicia M Forma. (2018) Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness. ClinicoEconomics and Outcomes Research 10, pages 573-585.
Read now
Read now
Carlos Roncero, Néstor Szerman, Antonio Terán, Carlos Pino, José María Vázquez, Elena Velasco, Marta García-Dorado & Miguel Casas. (2016) Professionals’ perception on the management of patients with dual disorders. Patient Preference and Adherence 10, pages 1855-1868.
Read now
Read now
Nestor Szerman, Pablo Vega, Lara Grau-López, Carmen Barral, Ignacio Basurte-Villamor, Beatriz Mesías, Laia Rodríguez-Cintas, José Martínez-Raga, Miguel Casas & Carlos Roncero. (2014) Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals. Journal of Dual Diagnosis 10:2, pages 84-90.
Read now
Read now
Jose Manuel Olivares, Manickam Thirunavukarasu, Jayashri Kulkarni, Hong Yan Zhang, Mingyuan Zhang & Fan Zhang. (2013) Psychiatrists’ awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey. Neuropsychiatric Disease and Treatment 9, pages 1163-1170.
Read now
Read now
Articles from other publishers (18)
Giovanni Ostuzzi, Federico Tedeschi, Federico Bertolini, Carlo Cotugno, Andrea Aguglia, Francesco Bartoli, Giuseppe Carrà, Armando D’Agostino, Giovanni Martinotti, Corrado Barbui, Chiara Gastaldon & Davide Papola. (2023) Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study. Schizophrenia 9:1.
Crossref
Crossref
Antonello Bellomo, Lucia Armini, Edwige Cuozzo, Laura De Masi, Fiammetta Gallone, Giuseppe Valentini Gravinese, Giuseppe Tricarico & Antonio Ventriglio. (2023) Descriptive analysis of pathways to Care and Rehabilitation among Psychiatric Offenders after the closing of Forensic Psychiatric Hospitals in Italy. RIVISTA SPERIMENTALE DI FRENIATRIA 147:1, pages 87-102.
Crossref
Crossref
Shuquan Zhang, Min Li & Zhenhua Guo. (2022) Effect of cannabidiol on schizophrenia based on randomized controlled trials: A meta-analysis. Annales Médico-psychologiques, revue psychiatrique 180:7, pages 630-638.
Crossref
Crossref
Katalin Pungor, Pedro Sanchez, Sofia Pappa, Jerome Attal, Karolina Leopold, Geertje Steegen, Antonio Vita, Carol Marsella, Caroline Verrijcken, Marjolein Lahaye & Annette Wooller. (2021) The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia. BMC Psychiatry 21:1.
Crossref
Crossref
Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, Srihari Gopal, Maju Mathews, Annette Wooller & Katalin Pungor. (2021) Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate. Comprehensive Psychiatry 107, pages 152233.
Crossref
Crossref
Joseph Cusimano & Amy VandenBerg. (2020) Long-acting injectable antipsychotics and their use in court-ordered treatment: A cross-sectional survey of psychiatric pharmacists' perceptions. Mental Health Clinician 10:1, pages 18-24.
Crossref
Crossref
Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova & Katalin Pungor. (2020) Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia. Therapeutic Advances in Psychopharmacology 10, pages 204512532092634.
Crossref
Crossref
Joep H. Schoemaker, Ad J.J.M. Vingerhoets & Robin A. Emsley. (2018) Factors associated with poor satisfaction with treatment and trial discontinuation in chronic schizophrenia. CNS Spectrums 24:4, pages 380-389.
Crossref
Crossref
Yan Li, Changjun Du, Ni JiaxiangYang Liqiang & Fang Qi. (2019) Olanzapine versus placebo for people with schizophrenia. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon & David Castle. (2016)
Recommendations for the optimal care of patients with recent‐onset psychosis in the
A
sia‐
P
acific region
. Asia-Pacific Psychiatry 8:2, pages 154-171.
Crossref
Crossref
Marwa Abdel-Rahman Sultan, Reem El Sayad Hashem, Nesreen Mohamed Mohsen, Doaa Helmy Barakat, Ramy Ali Ryad & Afaf Hamed Khalil. (2016) Studying medication adherence in patients with schizophrenia. Middle East Current Psychiatry 23:1, pages 27-34.
Crossref
Crossref
Robin Emsley, Koksal Alptekin, Jean-Michel Azorin, Fernando Cañas, Vincent Dubois, Philip Gorwood, Peter M. Haddad, Dieter Naber, José Manuel Olivares, Georgios Papageorgiou, Miguel Roca, Pierre Thomas, Ludger Hargarter & Andreas Schreiner. (2015) Nurses’ perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey. Therapeutic Advances in Psychopharmacology 5:6, pages 339-350.
Crossref
Crossref
A. Svettini, B. Johnson, C. Magro, J. Saunders, K. Jones, S. Silk, L. Hargarter & A. Schreiner. (2015) Schizophrenia through the carers' eyes: results of a European cross‐sectional survey. Journal of Psychiatric and Mental Health Nursing 22:7, pages 472-483.
Crossref
Crossref
Anas Najjar, Yazan Amro, Islam Kitaneh, Salam Abu-Sharar, Maryam Sawalha, Abrar Jamous, Muhannad Qiq, Enas Makharzeh, Bayan Subb Laban, Wafa Amro & Ahmad Amro. (2015) Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem. PLOS ONE 10:6, pages e0129240.
Crossref
Crossref
Jayashri Kulkarni & Kate Reeve-Parker. (2015) Psychiatrists’ awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey. Australasian Psychiatry 23:3, pages 258-264.
Crossref
Crossref
Mateus Rodrigues Tonetto, Alvaro Henrique Borges, Fábio Luis Miranda Pedro, Reidson Stanley Soares dos Santos, Alex Semenoff-Segundo, Matheus Coelho Bandeca, Alessandra Nogueira Porto & Tereza Aparecida Delle Vedove Semenoff. (2014) Effect of Chronic Stress on Ligature-induced Periodontitis in Inbred and Noninbred Rats: A Radiographic Study. The Journal of Contemporary Dental Practice 15:5, pages 556-560.
Crossref
Crossref
Pierre Michel Llorca, Mocrane Abbar, Philippe Courtet, Sebastien Guillaume, Sylvie Lancrenon & Ludovic Samalin. (2013) Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness. BMC Psychiatry 13:1.
Crossref
Crossref
Sarah C.E. Chapman & Rob Horne. (2013) Medication nonadherence and psychiatry. Current Opinion in Psychiatry 26:5, pages 446-452.
Crossref
Crossref